ATE534905T1 - Cop1-moleküle und verwendungen davon - Google Patents
Cop1-moleküle und verwendungen davonInfo
- Publication number
- ATE534905T1 ATE534905T1 AT04795352T AT04795352T ATE534905T1 AT E534905 T1 ATE534905 T1 AT E534905T1 AT 04795352 T AT04795352 T AT 04795352T AT 04795352 T AT04795352 T AT 04795352T AT E534905 T1 ATE534905 T1 AT E534905T1
- Authority
- AT
- Austria
- Prior art keywords
- cop1
- cop1 molecules
- molecules
- detecting
- provides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/9015—Ligases (6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Liquid Crystal Substances (AREA)
- Artificial Filaments (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2004/034174 WO2006043938A1 (en) | 2004-10-14 | 2004-10-14 | Cop1 molecules and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534905T1 true ATE534905T1 (de) | 2011-12-15 |
Family
ID=34959031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04795352T ATE534905T1 (de) | 2004-10-14 | 2004-10-14 | Cop1-moleküle und verwendungen davon |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7785815B2 (de) |
| EP (2) | EP1802978B1 (de) |
| JP (1) | JP4678882B2 (de) |
| CN (1) | CN101080638A (de) |
| AT (1) | ATE534905T1 (de) |
| AU (2) | AU2004324176B2 (de) |
| CA (1) | CA2584197A1 (de) |
| IL (2) | IL182500A0 (de) |
| MX (1) | MX2007004342A (de) |
| NZ (1) | NZ554438A (de) |
| WO (1) | WO2006043938A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1802978B1 (de) | 2004-10-14 | 2011-11-23 | Genentech, Inc. | Cop1-moleküle und verwendungen davon |
| US10261321B2 (en) | 2005-11-08 | 2019-04-16 | Lumus Ltd. | Polarizing optical system |
| EP1981984A2 (de) * | 2005-12-31 | 2008-10-22 | Genentech, Inc. | Phosphorylierte cop1-moleküle und verwendungen davon |
| KR101711860B1 (ko) * | 2008-01-25 | 2017-03-03 | 베르그 엘엘씨 | 발암성, 종양 진행 및 치료 효능을 평가하는 분석 시스템 |
| WO2009117448A1 (en) * | 2008-03-18 | 2009-09-24 | Mendel Biotechnology, Inc. | Enhancement of plant yield, vigor and stress tolerance |
| US9222086B2 (en) | 2009-09-23 | 2015-12-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing genes expressed in cancer |
| WO2012048276A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
| WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| EP3198006B1 (de) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Geplante fütterung |
| IL235642B (en) | 2014-11-11 | 2021-08-31 | Lumus Ltd | A compact head-up display system is protected by an element with a super-thin structure |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| JP7187022B2 (ja) | 2016-10-09 | 2022-12-12 | ルムス エルティーディー. | 長方形導波路を使用する開口乗算器 |
| CN113031165B (zh) | 2016-11-08 | 2023-06-02 | 鲁姆斯有限公司 | 导光装置、其光学组件及其对应的生产方法 |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| JP7174929B2 (ja) | 2017-07-19 | 2022-11-18 | ルムス エルティーディー. | Loeを介するlcos照明 |
| WO2020174433A1 (en) | 2019-02-28 | 2020-09-03 | Lumus Ltd. | Compact collimated image projector |
| KR20210151782A (ko) | 2019-04-15 | 2021-12-14 | 루머스 리미티드 | 광-유도 광학 소자 제조 방법 |
| CA3155597C (en) | 2019-12-08 | 2023-02-14 | Lumus Ltd. | Optical systems with compact image projector |
| DE202021104723U1 (de) | 2020-09-11 | 2021-10-18 | Lumus Ltd. | An ein optisches Lichtleiterelement gekoppelter Bildprojektor |
| EP4314244B1 (de) | 2021-03-23 | 2025-07-23 | Terumo BCT, Inc. | Zellerfassung und -erweiterung |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
| CN119587474A (zh) * | 2024-12-20 | 2025-03-11 | 中国人民解放军新疆军区总医院 | 一种肝靶向化疗药物纳米胶束制备方法、化疗药物及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5527676A (en) | 1989-03-29 | 1996-06-18 | The Johns Hopkins University | Detection of loss of the wild-type P53 gene and kits therefor |
| DE69233079T2 (de) * | 1991-02-01 | 2004-04-01 | OSI Pharmaceuticals, Inc., Uniondale | Immunoassay zum nachweis des mutanten p53 polypeptids in biologischen flüssigkeiten |
| US6020135A (en) * | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| US8053477B2 (en) * | 2002-03-29 | 2011-11-08 | University Of Maryland, Baltimore | Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same |
| DE60200248T2 (de) * | 2002-08-01 | 2005-01-27 | Mtm Laboratories Ag | Verfahren für Lösung-basierte Diagnose |
| EP1802978B1 (de) | 2004-10-14 | 2011-11-23 | Genentech, Inc. | Cop1-moleküle und verwendungen davon |
-
2004
- 2004-10-14 EP EP04795352A patent/EP1802978B1/de not_active Expired - Lifetime
- 2004-10-14 CN CNA2004800446163A patent/CN101080638A/zh active Pending
- 2004-10-14 EP EP10009858A patent/EP2302388A1/de not_active Withdrawn
- 2004-10-14 JP JP2007536670A patent/JP4678882B2/ja not_active Expired - Fee Related
- 2004-10-14 AT AT04795352T patent/ATE534905T1/de active
- 2004-10-14 CA CA002584197A patent/CA2584197A1/en not_active Abandoned
- 2004-10-14 NZ NZ554438A patent/NZ554438A/en unknown
- 2004-10-14 MX MX2007004342A patent/MX2007004342A/es active IP Right Grant
- 2004-10-14 WO PCT/US2004/034174 patent/WO2006043938A1/en not_active Ceased
- 2004-10-14 AU AU2004324176A patent/AU2004324176B2/en not_active Ceased
-
2007
- 2007-04-10 US US11/786,399 patent/US7785815B2/en not_active Expired - Fee Related
- 2007-04-12 IL IL182500A patent/IL182500A0/en unknown
-
2010
- 2010-06-29 US US12/826,537 patent/US20110045474A1/en not_active Abandoned
- 2010-09-15 AU AU2010219438A patent/AU2010219438A1/en not_active Withdrawn
-
2011
- 2011-02-17 IL IL211255A patent/IL211255A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004324176A1 (en) | 2006-04-27 |
| EP1802978B1 (de) | 2011-11-23 |
| US7785815B2 (en) | 2010-08-31 |
| IL211255A0 (en) | 2011-04-28 |
| JP2008517266A (ja) | 2008-05-22 |
| CN101080638A (zh) | 2007-11-28 |
| US20110045474A1 (en) | 2011-02-24 |
| EP1802978A1 (de) | 2007-07-04 |
| IL182500A0 (en) | 2007-09-20 |
| EP2302388A1 (de) | 2011-03-30 |
| US20080009458A1 (en) | 2008-01-10 |
| AU2010219438A1 (en) | 2010-10-14 |
| WO2006043938A1 (en) | 2006-04-27 |
| CA2584197A1 (en) | 2006-04-27 |
| JP4678882B2 (ja) | 2011-04-27 |
| NZ554438A (en) | 2009-11-27 |
| MX2007004342A (es) | 2007-07-16 |
| AU2004324176B2 (en) | 2011-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534905T1 (de) | Cop1-moleküle und verwendungen davon | |
| IL180997A0 (en) | Diagnostic methods and kits utilizing platelet biomarkers for cancer | |
| AU2006316189A8 (en) | Novel quantitative and qualitative analysis apparatus for measuring the body fluid | |
| ATE425266T1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
| GB0612649D0 (en) | No title | |
| DE602006002251D1 (de) | Messvorrichtungsanzeigevorrichtung, anzeigeverfahren dafür und damit ausgestattetes hybridfahrzeug | |
| AU305356S (en) | Analyte test meter | |
| ATE424560T1 (de) | Marker für neuromyelitis optica | |
| DE602005009702D1 (de) | Esr1 und gebärmutterhalskrebs | |
| WO2008048970A3 (en) | Synthetic antibodies | |
| WO2008039769A3 (en) | Methods and devices for analyzing small rna molecules | |
| EP1700096A4 (de) | Nachweis von proteinen und prionen mit veränderter konformation | |
| ATE513216T1 (de) | Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome | |
| WO2008048508A3 (en) | Prognostic biomarkers in patients with ovarian cancer | |
| DE602006019404D1 (de) | Docetaxel-immuntest | |
| WO2007092173A3 (en) | Raman spectroscopic lateral flow test strip assays | |
| DK1864129T3 (da) | Doxurubicin-immunassay | |
| WO2007056523A3 (en) | Methods for diagnosing and monitoring the progression of cancer | |
| ATE479898T1 (de) | Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs | |
| WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease | |
| EP1776470A4 (de) | Reagenzien, kits und verfahren für den immunnachweis von epitopen auf molekülen | |
| IL173843A0 (en) | Assay for coronaviruses, reagents for use therein and kits containing the same | |
| BRPI0606685A2 (pt) | anticorpos gitr para o diagnóstico de nsclc | |
| IL174195A0 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
| ATE533860T1 (de) | Reagenzien und verfahren zur detektion von neisseria gonorrhoeae |